Nuvation Bio Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Nuvation Bio Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
  • Nuvation Bio Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $7.89M, a 43.7% increase year-over-year.
  • Nuvation Bio Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $27M, a 69.9% increase year-over-year.
  • Nuvation Bio Inc. annual Nonoperating Income (Expense) for 2023 was $24M, a 54.6% increase from 2022.
  • Nuvation Bio Inc. annual Nonoperating Income (Expense) for 2022 was $15.5M, a 140% increase from 2021.
  • Nuvation Bio Inc. annual Nonoperating Income (Expense) for 2021 was $6.47M, a 242% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $27M $7.89M +$2.4M +43.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $24.6M $5.41M +$612K +12.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $24M $7.04M +$3.56M +102% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $20.5M $6.69M +$4.56M +213% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $15.9M $5.49M +$2.48M +82.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $13.4M $4.8M -$2.1M -30.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $15.5M $3.49M -$986K -22% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $16.5M $2.14M +$1.32M +163% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $15.2M $3.01M +$1.91M +174% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $13.3M $6.9M +$6.82M +8313% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $6.47M $4.48M +$3.99M +817% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.48M $812K +$300K +58.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.18M $1.1M +$683K +163% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.5M $82K -$392K -82.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1.89M $488K Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $512K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $418K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $474K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.